Synthomer’s (SYNT) Buy Rating Reaffirmed at Peel Hunt

Share on StockTwits

Synthomer (LON:SYNT)‘s stock had its “buy” rating reiterated by research analysts at Peel Hunt in a report issued on Monday, ThisIsMoney.Co.Uk reports.

Several other equities analysts have also recently issued reports on the company. UBS Group reiterated a “sell” rating on shares of Synthomer in a report on Monday, June 3rd. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Synthomer in a report on Thursday, May 23rd. Credit Suisse Group reiterated a “neutral” rating on shares of Synthomer in a report on Monday, May 6th. Numis Securities upgraded Synthomer to a “buy” rating in a report on Monday, April 29th. Finally, Deutsche Bank reiterated a “buy” rating on shares of Synthomer in a report on Thursday, April 18th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of GBX 486.40 ($6.36).

Shares of SYNT stock opened at GBX 371.20 ($4.85) on Monday. The company has a current ratio of 1.22, a quick ratio of 0.84 and a debt-to-equity ratio of 65.20. The firm has a market cap of $1.25 billion and a PE ratio of 12.71. Synthomer has a 52 week low of GBX 346.60 ($4.53) and a 52 week high of GBX 580.50 ($7.59).

In related news, insider Calum MacLean sold 73,905 shares of the firm’s stock in a transaction dated Tuesday, April 9th. The stock was sold at an average price of GBX 389 ($5.08), for a total value of £287,490.45 ($375,657.19).

Synthomer Company Profile

Synthomer plc operates as a specialty chemicals company in Europe, North America, Asia, and internationally. The company offers pressure-sensitive adhesives, acrylic polymers, acrylic dispersions, and other adhesives; latices for foamed bedding products and footwear; and binders for carpet applications.

Recommended Story: What is Cost of Debt?

Analyst Recommendations for Synthomer (LON:SYNT)

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

William I. Jacobs Sells 600 Shares of Global Payments Inc  Stock
William I. Jacobs Sells 600 Shares of Global Payments Inc Stock
Stewart Butterfield Sells 2,500 Shares of Slack  Stock
Stewart Butterfield Sells 2,500 Shares of Slack Stock
Alice Lindsay Caulder Sells 501 Shares of World Acceptance Corp.  Stock
Alice Lindsay Caulder Sells 501 Shares of World Acceptance Corp. Stock
Insider Buying: ALS Ltd  Insider Buys 14,983 Shares of Stock
Insider Buying: ALS Ltd Insider Buys 14,983 Shares of Stock
Opko Health Inc.  CEO Purchases $106,000.00 in Stock
Opko Health Inc. CEO Purchases $106,000.00 in Stock
Robert Langer Sells 7,500 Shares of Rubius Therapeutics Inc  Stock
Robert Langer Sells 7,500 Shares of Rubius Therapeutics Inc Stock


© 2006-2019 Ticker Report